The Blackstone Group and the Carlyle Group are said to be interested in acquiring Merck’s generic business. Both financial investors are believed to be in advanced talks with Indian pharmaceutical companies Ranbaxy and Cipla in order to partner up for a possible buyout.
Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Existing investors including Institut Català de Finances also take part in the financing
Biotech company initially raised €12m in December 2018